Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06734065 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Non-Invasive Lung Fluid Monitoring for Heart Failure Management in Primary Care

Study acronym: LiLAC-HF
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Apr 2025 to Apr 16, 2025v3 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 2025 to Apr 16, 2025
  2. Primary completion date: Jul 2029 to Jul 2030 Start date: Jan 2025 to Apr 2025 · Primary endpoint revised · Completion date: Dec 2029 to Dec 2030 · 2 morev2 Show 5 more changesShow less
    • Start date: Jan 2025 to Apr 2025
    • Primary endpoint revised
    • Completion date: Dec 2029 to Dec 2030
    • Eligibility criteria expanded, about 44 words
    • Secondary endpoints revised (9)

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Remote dielectric sensing (ReDS) technology offers a non-invasive method for assessing lung congestion. This randomized controlled trial aims to evaluate the effectiveness and processes of the ReDS-guided heart failure management program in primary care settings for patients with heart failure.
Trial Details
NCT Number NCT06734065
Lead Sponsor Linkoeping University
Conditions Heart Failure
Enrollment 330 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov